1Eferl R, Hoebertz A, Schilling AF, et al. The Fos-related antigen Fra-1 an activator of bone matrix formation [ J ]. EMBO J, 2004,23 ( 14 ) : 2789 -2799.
3Adiseshaiah P, Papaiahgari SR, Vuong H, et al. Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells [ J ]. J Biol Chem,2003,278 (48) :47423-47433.
4Reddy SP, Mossman BT. Role and regulation of activator protein-1 in toxicant-induced responses of the lung [ J ]. Am J Physiol Lung Cell Mol Physiol,2002,283 (6) : L1161 -L1178.
5Tulchinsky E. Fos family members : regulation, structure and role in oncogenic transformation [ J ]. Histol Histopathol,2000,15 (3) :921-928.
6Schreiber M, Wang ZQ, Jochum W, et al. Placental vaseularisation requires the AP-1 component fral[J]. Development, 2000,127 ( 22 ) : 4937 -4948.
7Zhang Q, Kleeberger SR, Reddy SP. DEP-induce fra-1 expression correlates with a distinct activation of AP-l-dependent gene transcription in the lung[ J ]. Am J Physiol Lung Cell Mol Physiol,2004,286 (2) : L427-L436.
8Casalino L,De Cesare D,Verde P. Accumulation of Fra-I in ras-transformed cell depends on both transcriptional autoregulation and MEK- dependent posttranslational stabilization [ J ]. Mol Cell Biol, 2003,23 (12) :4401-4415.
9Young MR, Nair R, Bueheimer N, et al. Transaetivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regnlated ki. nase dependently[ J ]. Mol Cell Biol,2002,22 (2) :587-598.
10Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis[ J]. Eur J Cancer,2005,41 (16) :2449-2461.
2Tulchinsky E. Fos family members: regulation, structure and role in oncogenic transformation [J]. Histol Histopathol, 2000, 15(3) :921-928.
3Milde LK. The Fos family of transcription factors and their role in tumourigenesis[J]. Eur J Cancer, 2005, 41(16) : 2449-2461.
4Bergers G, Graninger P, Braselmann S, et al. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron [J]. Mol Cell Biol, 1995, 15(7) :3748- 3758.
5Vallone D, Battista S, Pierantoni GM, et al. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product [J]. EMBO J, 1997, 16(17) :5310-5321.
6Chiapetta G, Tallini G, De Biasio MC, et al. Fra-1 expression in hyperplastic and neoplastic thyroid diseases[J]. Clin Cancer Res, 2000, 6(11):4300-4307.
7Mangone FR, Brentani MM, Nonogaki S, et al. Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma [J]. Int J Exp Pathol. 2005, 86(4) :205-212.
8Belguise K, Kersual N, Galtier F, et al. Fra-1 expression level regulates proliferation and invasiveness of breast cancer cells [J]. Oncogene, 2005, 24(8):1434-1444.
9Andersen H, Mahmood S, Tkach V, et al. The ability of Fos family members to produce phenotypic changes in epitheloid cells is not directly linked to their transactivation potentials[J]. Oncogene, 2002, 21(31):4843-4848.
5Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis[J]. Eur J Cancer,2005,41 (16) :2449-2461.
6Passegue E, Wagner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression[J]. EMBO J,2000, 19 : 2969-2979.
7Akaji K, Suga S, Fujiho T, et al. Effect of intra-ischemic hypothermia on the expression of c-fos and c-jun, and DNA blinding activity of AP- 1 after focal cerebral ischemia in rat brain[J]. Brain Res,2003,975 (1-2) :149-157.
8Jiang H, Wang MX, Guo J, et al. The midnight-noon ebb-flow point selection for 30 cases of acute ischemlc cerebrovascular diseases[ J]. Tradeit Chin Med ,2008,28 ( 3 ) : 193.
9Zhao LR, Spellman S, Kim J. Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemiain rats [ J ]. Brain Res,2005,1054 ( 1 ) : 1.
10Jame Richebe, Philippe M, Rathmell SP, et al. Immediate Early Genes after Pulsed Radiofrequency Treatment : Neurobiology in Need of Clinical Trials [ J ]. Anesthesiology,2005,102 ( 1 ) : 1-3.
